Ozempic (Semaglutide) for the treatment of obesity: advantages and disadvantages from an integrative analysis. Research, Society and Development, [S. l.], v. 11, n. 11, p. e587111133963 , 2022. DOI: 10.33448/rsd-v11i11.33963. Disponível em: https://rsdjournal.org/rsd/article/view/33963. Acesso em: 5 dec. 2025.